<DOC>
	<DOCNO>NCT02700191</DOCNO>
	<brief_summary>Subjects treat Congestive Heart Failure clinic Nazareth give µ-Cor system add standard care , randomize 1:1 interventional arm control arm .</brief_summary>
	<brief_title>Cardiovascular Diagnosis Using µ-Cor - Interventional Pilot Trial</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Men woman 2090 year old . New York Heart Association ( NYHA ) class IIIIV heart failure Followed Congestive Heart Failure ( CHF ) clinic Nazareth Left ventricular ejection fraction &lt; 35 % Requiring treatment &gt; 40mg/day furosemide* orally repeat bolus intravenous infusion furosemide* ( *or equivalent bumetanide torasemide ) . Pregnancy Subjects receive heart transplant . Subjects unable unwilling follow study requirement . Patients allergy skin sensitivity electrode hydrogel and/or acrylic base adhesive . Patients skin breakdown area chest device electrode placement require</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>